Gastroesophageal reflux disease presenting as xerophthalmia.
Davitt
B V
BV
Department of Ophthalmology, Saint Louis University School of Medicine, MO, USA.
Berdy
G
G
Kane
R E
RE
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005764:Gastroesophageal Reflux / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D064747:Lansoprazole; D008297:Male; D009824:Ointments; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011899:Ranitidine / Q000627:therapeutic use; D014801:Vitamin A / Q000097:blood / Q000627:therapeutic use; D014802:Vitamin A Deficiency / Q000175:diagnosis / Q000188:drug therapy; D014985:Xerophthalmia / Q000175:diagnosis* / Q000188:drug therapy
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D009824:Ointments; D064747:Lansoprazole; D014801:Vitamin A; D011899:Ranitidine; D009853:Omeprazole